Tag: multiparametric MRI

A high PSA result sounds alarming but it doesn't automatically mean cancer. Other factors can raise PSA, and until recently, the only way to know more was a biopsy. Now, two major breakthroughs are reshaping prostate cancer screening in ways that protect men from unnecessary procedures. keep reading

For men dealing with BPH, the urinary symptoms are just part of the story. The condition is now linked to measurable increases in depression and anxiety. Focal laser ablation at Sperling Prostate Center precisely reduces obstructing prostate tissue, helping men reclaim both their health and their wellbeing. keep reading

What if you could eliminate a prostate cancer tumor while keeping nearly everything else intact? That's the promise of focal therapy — and it's no longer a fringe idea. Backed by stronger imaging tools and better biopsy methods, focal therapy now delivers cancer control that rivals surgery, with far fewer side effects keep reading

Most men with radiation-recurrent prostate cancer once had few good options — hormone therapy delayed the disease but offered no hope of cure. Today, focal salvage ablation is changing that picture. Now, a global expert panel has outlined the clinical trial standards needed to put this promising treatment on solid scientific footing. keep reading

Less than a third of men with a PSA result in the "gray zone" of 4–10 actually have prostate cancer. Yet for years, that number alone sent patients straight to biopsy. Today, mpMRI offers a smarter first step and a newly FDA-approved blood test called IsoPSA may be the safety net for cases MRI can't fully resolve. keep reading

Half of all men will deal with prostatitis at some point. The problem? Its symptoms — pelvic pain, urinary trouble, elevated PSA — can look almost identical to prostate cancer on standard tests. Before rushing to a biopsy, there's a better path: 3T multiparametric MRI can tell the difference with high accuracy and no needles required. keep reading

Multifocality has shaped prostate cancer treatment for years, but research shows some cases are unifocal and may qualify for less invasive focal therapy. Careful clinical evaluation is key to tailoring the best treatment approach. keep reading

Focal therapy gives men with localized prostate cancer an appealing option—effective control with fewer side effects. Discover who qualifies for focal treatment, how it compares to radical approaches and Active Surveillance, and why specialized diagnosis is essential. keep reading

Imagine seeing even clearer prostate images than today’s advanced 3T MRI allows—5T MRI could make that a reality. While research teams report remarkable image quality and better tumor visibility with 5T, economic and practical challenges mean that 3T MRI remains the standard for prostate cancer screening and treatment guidance. keep reading

Deciding on Active Surveillance for prostate cancer isn’t always straightforward. Adding genomic testing to standard factors like PSA, MRI, and biopsy can reveal hidden risks and help ensure the safest, most personalized treatment path. keep reading